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Fenugreek is an annual crop belonging to the legume family grown in 
most parts of the world. It is known to possess a number of medicinal 
properties, but a little phytochemical research has been carried out on the 
seeds of species; Trigonella hamosa Leguminosae. Previously we reported 
that Trigonella seeds extract are shown to have hypoglycemic effects on 
experimental diabetic rats. The aim of the current study is to understand the 
molecular mechanism of antidiabetic actions of Trigonella. Therefore, we 
examined the expressions levels of genes involved in glucose metabolism in 
liver of diabetic rats. Upon this basis, streptozotocin (STZ)-diabetic rats are 
used to assess hepatic glucokinase (GCK), insulin like growth factor-1 (IGF-
1), and glucose transporters (GLUT-2) genes expressions after Trigonella 
administration by oral intragastric intubation for two months, using RT-PCR 
assay. The current findings demonstrated that Trigonella reduced 
significantly glucose level in diabetic rats, while significantly increases 
insulin serum level. GCK expression levels in hepatic tissue of diabetic-rats 
are found to be suppressed, while Trigonella treatment induces an increase in 
hepatic GCK activity. Diabetes due to STZ has a little effect on IGF-1 gene 
expression, while Trigonella administration elevates mRNA expression 
significantly. On the other hand, Trigonella reduce and normalize the 
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elevation of GLUT-2 gene expression, which increased due to STZ 
treatment. These results indicated that Trigonella are powerful antidiabetic 
agent, induce hypoglycemia by up-regulation of CGK and IGF-1 genes 
expression and induce an insulin mimetic activity. 
 




 Diabetes mellitus (DM) is a chronic metabolic disease occurred due 
to either destruction of pancreatic β-cells or insulin resistance occurred as 
results of obesity and its related metabolic disorders (Hall, 2003; Havel, 
2004). The two major types of DM; diabetes type 1 and diabetes type 2, are 
characterized by hyperglycemia, abnormal lipid and protein metabolism 
leading to many complications affecting human body systems (Mathur et al., 
2011). Patient with diabetes for long term are at higher risk of heart disease, 
stroke, high blood pressure, blindness, kidney disease, nervous system 
disease, amputations, dental disease, and complications of pregnancy (Akinci 
et al., 2003). A disease of diabetes is remaining to be an expanding global 
health crisis, and expected to affect 300 million people by 2025 (Hjelm et al., 
2003). In Kingdom of Saudi Arabia (KSA), diabetes has become more 
evident in the last two decades as a result of dramatic changes in the life 
style (Ammari, 2004). The prevalence of diabetes in KSA is now considered 
one of the highest in the world reaching as high as 23.7% of population 
(Alwakeel et al., 2009). Regrettably, DM is one of the five leading causes of 
death worldwide (Caliskan et al., 2006). 
 Patients suffer from diabetic prefer to use dietary modulators has 
antidiabetic activity to control blood glucose level. This tendency is because 
insulin cannot be used orally and its repeated injections have many 
undesirable adverse effects. In addition, most of hypoglycemic agents or 
drugs are not effective to decrease blood glucose levels in chronic diabetic 
patients (Cheng and Fantus, 2005). For these reasons, foods of medicinal 
value have been proved effective and thus are widely used as they combine 
two basic central factors: food and medication (Mohieldein et al., 2011; 
Oubre et al., 1997).  
 Annual coumarin-smelling herb Trigonella hamosa Leguminosae 
(Trigonella glabra Thumb) is one of the best known member of the herb 
fenugreek, grows as a weed in Egypt, the East Mediterranean region, and 
from KSA to Afghanistan and India (Boulos, 1999; Grower et al., 2002). We 
and others reported that fenugreek seeds can lower blood glucose and 
cholesterol in experimental diabetic animals (Khosla et al., 1995; Puri et al., 
1995; Kumar et al., 2005; Puri et al., 2002; Salah-eldin et al., 2007). Also, 
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several studies included us, demonstrated that some plant extracts belonging 
to the fenugreek family decreased oxidative stress and enhanced the 
activities of several components of the endogenous antioxidant system 
(Annida et al., 2005; Anuradha and Ravikumar, 2001 ; Siddiqui et al., 2005; 
Salah-eldin, 2008).  
 The diabetogenic agent streptozotocin, used in this study, is 
selectively toxic to insulin-secreting β-cells of pancreatic islets (Strandelle et 
al., 1989), and it induced significant hyperglycemia accomplished by a 
decrease in insulin levels (Hussain, 2002; Sellamuthu et al., 2009). Liver is 
an insulin-sensitive tissue and plays a major role in maintaining glucose 
homeostasis by regulating the interaction between the glucose utilization and 
production. Thus, a suitable antidiabetic agent should improve glucose-
induced insulin secretion, hepatic glucose metabolism, and peripheral insulin 
sensitivity (Ferre et al., 1996). It has been demonstrated that, Trigonella 
exerts its protective effects in diabetes by decreasing morphological changes 
and preserving pancreatic ß-cell integrity (Salah-eldin et al., 2007), and by 
beneficially changing the hepatic antioxidants enzyme activities (Salah-eldin, 
2008).  
 Diabetes treatment depends mainly on regulation of genes related to 
glucose and/or carbohydrate metabolism. Glucose must be first 
phosphorylated before being utilized by cells. This reaction is catalyzed by a 
family of enzymes called hexo-kinases, which are found in different 
organisms including humans (Cardenas et al., 1998). Mammalian 
glucokinase plays a key role in maintaining glucose homoeostasis 
(Matschinsky et al., 2006), and is the major glucose-phosphorylating enzyme 
expressed in hepatocytes and pancreatic β-cells. GCK is one of the essential 
factors for the glucose-stimulated insulin secretion (Bourbonais et al., 2012). 
Long-term regulation of hepatic GCK activity is controlled by its mRNA 
level. In the liver, expression of GCK is very closely dependent on the 
presence of insulin. Stimulation of transcription of genes encoding GCK, 
leads to a decreased glucose level (Celik and Erdogan, 2008).  
 Also, liver tissues might be the main source of circulating insulin like 
growth factor-1 (Pankov, 1999; Catanese et al., 1993). It was reported that, 
IGF-1 may probably involved in metabolic abnormality and complications 
associated with diabetes (Goya et al., 1999). IGF-1 is protein with high 
sequence similarity to insulin, widely present in mammalian tissues and has a 
number of bioactivities including regulation of metabolism and enhancement 
of growth and development of tissues (Pankov, 1999; Thrailkill, 2000; Cusi 
and DeFronzo, 2000; Zhuang et al., 1997). Moreover, glucose transport is the 
rate limiting step in carbohydrate metabolism (Maughana, 2009) which is 
facilitated by glucose transporters; GLUT-2 across the cell membrane 
(Anand et al., 2010). So, drugs facilitate GLUT-2 translocation and improve 
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insulin sensitivity together with carbohydrate and lipid metabolism could be 
beneficial for the treatment of diabetes (Kipmen-Korgun et al., 2009; 
Shepherd and Kahn, 1999). Therefore, the effect of Trigonella on the 
expression levels of GCK, IGF-1, and GLUT-2 genes were assessed in liver 
of diabetic rats to evaluate the molecular mechanism of action. 
 Recently there has been a growing interest in hypoglycemic agents 
from natural products, especially those derived from plants, because plant 
sources are usually considered to be safer, with fewer side effects than 
synthetic sources (Goldfrank et al., 1982; Sabu et al., 2002; Mentz and 
Schenkel, 1989). Trigonella effects on genes control carbohydrate have not 
been examined yet. Therefore an attempt has been made to investigate the 
molecular mechanism of Trigonella in lowering and control glucose levels in 
experimentally diabetic animals. Herein, the effect of Trigonella on the 
expression levels of GCK, IGF-1 and GLUT-2 genes were assessed in liver 
of STZ-induced diabetic rats using reverse transcription polymerase chain 
reaction (RT-PCR) assay. 
  
Materials and methods: 
1. Chemicals: 
 Streptozotocin (Streptozocin, STZ), agarose, ethidium bromide, 
chloroform, and isopropanol were purchased from Sigma Chemical Co, St. 
Louis, Mo, USA. Vehicles and related materials were from ADWIA 
pharmaceutical Co, Egypt. Oligo dT and primers were from Wako pure 
chemicals, Osaka, Japan. TriZol reagent was from Invitrogen, Carlsbad, CA. 
All other chemicals and reagents used will be of analytical grade. 
 
2. Plant Material and Extract Preparation: 
 Seeds of Trigonella hamosa Leguminosae were chosen for the 
present study were collected and identified according to Boulos, (1999). 
Trigonella seeds are kindly obtained from the herbarium of the botany at 
faculty of science, Aswan University, Egypt. The active ethanolic fraction 
contains steroid saponins extract was prepared as previously describe by 
Salah-eldin et al. (2007).  
 
3. Induction of Diabetes in Wistar Rats: 
 Wistar albino rats were purchase from Egyptian Co for Experimental 
Animals Import, Helwan, Egypt. Diabetes mellitus were induced in albino 
rats by a single intraperitoneal (i.p.) injection of STZ (66 mg/kg body 
weight) dissolved in 0.1 m. citrate buffer (pH 4.5) to overnight fasted rats 
(Hancu et al., 1998). After STZ injection, the rats will have free access to 
food and water and will be given 5% glucose solution to drink overnight to 
counter hypoglycemic shock. After three days, the fasting blood glucose 
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levels will be determined and rats showing fasting blood glucose more than 
200 mg% will be considered diabetic and will be selected for the 
experimentation.  
 
4. Experimental Design and Samples Collection:  
 A total of thirty six healthy male rats of 7 to 8 weeks old and 
weighing over 200 grams were used. All rats were kept for acclimatization 
for one week under laboratory condition. The rats were providing with food 
pelleted and tap water ad libitum and randomized into three groups. 1st group 
was normal non-diabetic control (Cont), and two diabetic experimental 
groups. The diabetic groups of rats were injected ip with STZ, and rats were 
divided into two group; the 2nd known as STZ diabetic (STZ-Diab) rats 
group received water only. The 3rd group treated with saponins aqueous 
extract at a dose of 45 mg/kg body weight known as diabetic rats treated with 
Trigonella (Diab+Trig). 
 1st Group:    12 rats, normal non-diabetic control (Cont). 
 2nd Group: 12 rats, STZ diabetic (STZ-Diab). 
 3rd Group:  12 diabetic rats, treated with Trigonella (Diab+Trig). 
 Trigonella treatments were continued for two months by gastric tube, 
on a daily basis. Six rats were sacrificed by decapitation from each group 
after the experimental period of one and two months.  
 
5. Blood Glucose and Insulin Levels Estimation: 
 Blood was collected for the biochemical analyses after decapitation. 
Bio Merieux Co. (Marcy-L-Eto-L charobonnieres Les Bains, France) kits 
were used for colorimetric determination of plasma glucose; it was 
determined enzymatically according to Cooper and Daniel, (1970). Insulin 
levels were determined by radio immunoassay kits according to Goetz et al., 
(1963). Livers tissues were collected from all groups, washed by normal 
saline solution, dried by towel, flash frozen in liquid nitrogen and 
subsequently frozen at –70ºC until the time of RNA extraction and reverse 
transcriptase polymerase chain reaction (RT-PCR) analysis. 
 
6. Total RNA Isolation and RT-PCR Assay for Selected Genes in Liver: 
 The Primers of GCK (Mahmoodi et al., 2013), IGF-1 (Hwang et al., 
2009), and GLUT-2 (Soliman et al., 2013) genes were taken from literature. 
β-actin (Hwang et al., 2009) gene was used as an internal standard 
(housekeeping gene). The primers were checked for their Tm values, hairpin 
loops, dimers, cross-dimers and number of repeats and runs using Net Primer 
(Oligoanalyzer 3.1). Frozen liver samples of each group were thawed and 
used for RNA extraction. Homogenization of 200 mg of frozen tissue 
samples was carried after addition of 1 mL TriZol (Invitrogen, Carlsbad, 
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CA) using a Polytron 300 D homogenizer (Brinkman Instruments, Westbury, 
NY). One milliliter of the tissue homogenate was transferred to a microfuge 
tube and total RNA was extracted via chloroform extraction followed by 
nucleic acid precipitation with isopropanol. The pellet was washed with 75% 
ethanol and resuspended in molecular biology grade water. Nucleic acid 
concentration was determined by optical density at 260 nm (Smart-Spec; 
Bio-Rad Laboratories, Hercules, CA) and RNA integrity was evaluated using 
an Agilent bioanalyzer (model 2100; Agilent Technologies, Foster City, 
CA). The purity of RNA at 260/280 OD ratio and RNA integrity was 
evaluated and only a high purity samples (OD 260/280 >1.8) were subjected 
to further manipulation.  
 For cDNA synthesis, total RNA (1 μg) was denatured at 72°C for 5 
min and then reverse transcribed using 100  units of Moloney Murine 
Leukemia virus reverse transcriptase (Gibco), 50 pmol of oligo (dT) primer 
and 20 nmol of dNTPs in a total volume of 10 μL at 37°C for 1 h. After 
heating at 94°C for 5 min, PCR amplification was performed with 2.5 units 
Taq DNA polymerase (Perkin-Elmer, Foster City, CA, USA), 3 mM MgCl2 
and 50 pmol of forward and reverse primers specific for respective genes in a 
total volume of 50 μL. The RT-PCR conditions were as follows: cycling for 
35-40 cycles, each cycle consisting of denaturation for 30 sec at 94ºC 
followed by annealing for 30 sec at 52-55ºC (according to gene of interest as 
described in Table 1) and extension for 1 min at 72ºC. The template 
concentration and the cycle number were optimized to ensure linearity of 
response and to avoid saturation of the reaction. The PCR products were 
resolved and electrophoresed in 1.5% agarose gels, stained with ethidium 
bromide and visualized under UV lamp. The bands were identified based on 
the product size and documented using a Gel documentation system (Gel 
DocTMXR System, Bio-Rad) and the prints were scanned. The scanned 
images were quantified densitometrically with the aid of NIH image program 
(http//rsb.info.nih.gov/nih-imag/). The results were normalized to the levels 
obtained for the β-actin gene by taking a ratio of the value obtained for the 
gene of interest to that of β-actin and then relative to the control. 





7. Statistical analysis:  
 Results obtained are expressed as means ± standard error (X ± SE). 
To determine differences among the treated groups, data were statistically 
analyzed using a computerized one-way ANOVA followed a by t-test, 
according to Sendecor and Cochron, (1982). Differences between means 
were considered significant with a value of P ≤ 0.05.  
 
Results 
 It is clear from the previous study that the harmful effects of chronic 
diabetes appeared after 20 days and reached a maximum after 30 days of 
experiment (Salah-eldin et al., 2007). Our further study was carried out on 
how Trigonella supplementation of the diet countered the harmful effects of 
chronic diabetes, by improving antioxidant defense and oxidative damage, 
after one month of treatment (Salah-eldin, 2008). Since insulin was 
decreased in diabetic-rats and Trigonella administration normalized blood 
sugar level, we investigate the molecular mechanism of Trigonella action as 
a hypoglycemic agent by analysis the expressions levels of GCK, IGF-1 and 
GLUT-2 genes in normal control non-diabetic, diabetic, and diabetic-treated 
rats using RT-PCR assay.  
 
1. Glucose and Insulin Levels Recovered by Trigonella Treatment: 
 It is well established that STZ causes destruction of pancreatic  -
cells, leading to a marked reduction in serum insulin level and 
hyperglycemia. Figures 1 and 2 showed the variation in the levels of blood 
glucose and insulin, respectively during experiments. The level of glucose 
was significantly (P ≤ 0.05) elevated in STZ-diabetic rats (STZ-Diab) after 
four days of treatment and persisted throughout the experiment. After one 
and two months of STZ injection, rats showed markedly elevation in blood 
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glucose levels, and the values recorded reached 633.3 mg% and 566.2 mg%, 
respectively (Figure 1). We found a sign of recovery in glucose levels after 
treatments by Trigonella. In diabetic-treated group (Diab+Trig), Trigonella 
induce a significantly (P ≤ 0.05) lowering in glucose levels to 394.3 mg% 
and 142.1 mg% after one and two months of experiments, respectively. 
 
Figure (1): Variations in the glucose levels in non-diabetic control (Cont) rats, 
streptozotocin-diabetic (STZ-Diab) rats, and diabetic-rats received oral Trigonella extract 
(Diab+Trig) after one and two months of experiments (n=6). (*) Values are significant 
different (P ≤ 0.05) compared to control. (#) Values are significant different (P ≤ 0.05) 
compared to diabetic group control. 
 
 A severe reduction in serum insulin levels due to STZ treatment in 
STZ-Diab group, from 7.8 mIU/ml to 3.9 mIU/ml after one month, and from 
8.1 mIU/ml to 4.5 mIU/ml after the second month of experiments (Figure 2). 
A significant (P ≤ 0.05) recovery of insulin levels was recorded to 5.4 
mIU/ml and 7.1 mIU/ml in diabetic-treated group with Trigonella after the 
first and second month, respectively. The present study clarified that 
Trigonella increases insulin levels by elevating insulin synthesis and 
secretion.  
 
Figure (2): Variations in the insulin levels in non-diabetic control (Cont) rats, streptozotocin-
diabetic (STZ-Diab) rats, and diabetic-rats received oral Trigonella extract (Diab+Trig) after 
one and two months of experiments (n=6). (*) Values are significant different (P ≤ 0.05) 
compared to control. (#) Values are significant different (P ≤ 0.05) compared to diabetic 
group control. 
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 These data indicated that rats in STZ-Diab group did not grow 
normally, which would be expected, because their insulin levels were very 
low and glucose levels were too high. The decrement in plasma insulin level 
in STZ-Diab rats may be due to destruction of β-cells. Meanwhile, 
Trigonella administration in Diab+Trig group increased insulin levels 
significantly near to control levels. The results of insulin were reflected on 
glucose levels, which were higher in diabetic rats but normalized after two 
months of Trigonella administered in diabetic rats.  
 
2. RT-PCR Analysis for Genes Modulate Carbohydrate Metabolism in 
Hepatic Tissue: 
 To investigate the alteration in carbohydrate metabolism by 
Trigonella, mRNA from liver tissue was subjected for RT-PCR analysis. The 
expressions levels of GCK, IGF-1 and GLUT-2 genes were assessed in 
normal control albino rats (Cont), STZ-diabetic (STZ-Diab) rats, and 
diabetic rats treated with Trigonella (Diab+Trig) groups. 
2.1. GCK Gene Expression in Liver after Trigonella Administration: 
 The mRNA levels of glucokinase in rat’s liver were analysis. The 
expression level of the GCK gene in the normal control group (Cont) was 
considered as reference to calculate and normalize the expression in the other 
groups. Comparing with control rats, diabetes was found to suppress GCK 
gene expression slightly in liver tissue in STZ-Diab group (Figure 3). 
Trigonella treatment in Diab+Trig group elevated hepatic GCK gene 
expression when compared with the control and diabetic groups after one 
and two months of treatments. RT-PCR results showed that, Trigonella 
administration in diabetic rats induced a significant (P ≤ 0.05) increase in the 
gene expression after one and two months to 141.1 % and 169.2%, 
respectively.  
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Figure (3): RT-PCR analysis of GCK expression in liver tissues. Data of control non-
diabetic (Cont), experimentally diabetic (STZ-Diab), and Trigonella-treated diabetic rats 
(Diab+Trig) are shown after one and two months. RNA was extracted and reverse 
transcribed (1 μg) and then RT-PCR analysis was carried out for GCK gene. The 
densitometric analysis of the expresses bands after one month (a) and two months (b) of 
treatments. Data were normalized with that of β-actin and then calculated as relative to the 
control group (c). (*) Values are significant different (P ≤ 0.05) compared to control. 
(#)Values are significant different (P ≤ 0.05) compared to diabetic group control. 
 
2.2. IGF-1 Gene Expression in Liver after Trigonella Administration: 
 Herein, data shown that insulin levels sharply decreased in diabetic 
rats, and then increased near to non-diabetic control after Trigonella 
treatment. In this study, a change in insulin like growth factor 1 expression 
was non-significantly increased in diabetic as shown in Figure 4 compare to 
control non-diabetic rats. After Trigonella administration for two months 
only, IGF-1 mRNA expression is significantly (P ≤ 0.05) increased. The over 
expression of this gene was recorded when diabetic rats treated with 
Trigonella in Diab+Trig group compare to normal control and diabetic-
untreated rats. 




Figure (4): RT-PCR analysis of IGF-1expression in liver tissues. Data of control non-
diabetic (Cont), experimentally diabetic (STZ-Diab), and Trigonella-treated diabetic rats 
(Diab+Trig) are shown after one and two months. RNA was extracted and reverse 
transcribed (1 μg) and then RT-PCR analysis was carried out for IGF-1 gene. The 
densitometric analysis of the expresses bands after one month (a) and two months (b) of 
treatments. Data were normalized with that of β-actin and then calculated as relative to the 
control group (c). (*) Values are significant different (P ≤ 0.05) compared to control. 
(#)Values are significant different (P ≤ 0.05) compared to diabetic group control. 
 
2.3. GLUT-2 Gene Expression in Liver after Trigonella Administration: 
 Trigonella administration normalized the increase in glucose in 
diabetic rats, and decreased insulin level. So, we tested the physiological 
importance of insulin dependent glucose transporter 2 translocation. STZ 
administration in STZ-Diab group was found to increase GLUT-2 gene 
expression non-significantly (P ≤ 0.05) in liver compared to control rats after 
one and two months of treatments (Figure 5). In Diab+Trig group, Trigonella 
reduce hepatic GLUT-2 gene expression when compared with the diabetic 
group. As shown in Figure 5, diabetic rats showed an increase in GLUT-2 
mRNA expression and that increase was inhibited and become close to 
control after Trigonella administration in a way to regulate the excessive 
hepatic glucose utilization.  
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Figure (5): RT-PCR analysis of GLUT-2 expression in liver tissues. Data of control non-
diabetic (Cont), experimentally diabetic (STZ-Diab), and Trigonella-treated diabetic rats 
(Diab+Trig) are shown after one and two months. RNA was extracted and reverse 
transcribed (1 μg) and then RT-PCR analysis was carried out for GLUT-2 gene. The 
densitometric analysis of the expresses bands after one month (a) and two months (b) of 
treatments. Data were normalized with that of β-actin and then calculated as relative to the 
control group (c). (*) Values are significant different (P ≤ 0.05) compared to control. 
(#)Values are significant different (P ≤ 0.05) compared to diabetic group control. 
 
Discussion 
 Diabetes is a chronic metabolic disorder that affects approximately 
3% of population worldwide (Kim et al., 2009). Many sufferers from 
diabetes become aware that they are diabetic, only when they develop one of 
its life-threatening complications. Knowledge and awareness about DM, its 
risk factors, complications and management are important aspects for better 
control and good quality of life (Wild et al., 2004; Ángeles-Llerenas et al., 
2005). Usage of oral hypoglycemic drugs to treat diabetes has several 
limitations, such as adverse effects and high rates of secondary failure (Kim 
et al., 2009). Those adverse effects forced the diabetic patients to use herbal 
medication that has a similar degree of efficiency without side effects. 
Keeping in mind, the sustained reductions in hyperglycemia will decrease 
the risk of developing microvascular diseases and reduce diabetes 
complications (Gaster and Hirsch, 1998).  
 Changes in gene expression are an important component of the 
pathogenesis of diabetes (Yechoor et al., 2002; Sreekumar et al., 2002). In 
recent years, numerous plant extracts and plant formulations have been 
shown to regulate the expression of genes in metabolic pathways of different 
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diabetic animal models (Xu et al., 2009; Kim et al., 2009; Kwon et al., 
2005). Also, multiple transcription factors are involved in the regulation of 
carbohydrate metabolism either directly or through interaction with insulin, 
and a large number of insulin-regulated genes have been identified in liver 
tissue (O’Brien and Granner, 1996). Our previous studies have reported the 
hypoglycemic effect and antihyperlipidemic potency of Trigonella in STZ-
induce diabetes in rats (Salah-eldin et al., 2007; Salah-eldin, 2008), while the 
mode of action of this plant is not reported yet. 
 Present study revealed that, injection of STZ at dose of 66 mg/kg 
body/weight induced significant hyperglycemia in albino rats. This dose 
caused damage to  -cells of the islets of Langerhans and emergence of 
clinical diabetes within four days as results of autoimmune process (Weiss, 
1982), and STZ treatment induced significant hyperglycemia (Hussain, 2002; 
Sellamuthu et al., 2009). STZ causes destruction of  -cells of pancreas 
resulting in marked decrease in insulin levels, it could be predicted that 
glycogen levels in tissues (muscle and liver) decrease as the influx of glucose 
in liver is inhibited in the absence of insulin and recovers on insulin 
treatment (Vats et al., 2004). Hyperglycemia may be attributed to 
enhancement of gluconeogenesis as a result of absence of insulin (Yao et al., 
2006). 
 Hepatic glucokinase is a key enzyme in glucose homeostasis, and it is 
a potential target for treatment strategies of diabetes. It was reported that 
glucokinase enzyme activity was decreased by more than 90% in the liver 
diabetic rats (Zhang et al., 2009). So, in the current study, we evaluate the 
antidiabetic mechanism(s) of Trigonella, on the key enzyme of carbohydrate 
metabolism at mRNA level in livers of diabetic rats using RT-PCR. In this 
study, GCK expression levels in the livers of diabetic rats were slightly 
suppressed, while Trigonella-treated diabetic group showed an increased. 
The increased activity of hepatic GCK in the Trigonella treated group may 
cause an increase in glycolysis and utilization of glucose for energy 
production. Run in agreement with our data, it has been reported that GCK-
knockout mice have mild hyperglycemia (Postic et al., 1999), whilst rats 
over expressing GCK in the liver have reduced blood glucose (Ferre et al., 
1996).  
 Current results demonstrate that Trigonella reduce significantly 
glucose level in diabetic rats. The decrease in the blood glucose 
concentration in Trigonella treated diabetic rats may be associated with 
enhancement of GCK mRNA expression in the liver, thus increasing the 
level of glycolysis. In addition, blood insulin concentrations were increased 
in Trigonella-treated groups compared with the diabetic untreated group. 
This suggests that insulin may be enhances transcription of GCK gene in 
hepatocytes (Iynedjian et al., 1989; Matschinsky et al., 1993), which employ 
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a different promoter than that employed by  -cells (Shelton et al., 1992). 
This agrees with the finding that hepatic glycolytic enzyme activity is 
controlled primarily at the transcription level by insulin (Friedman et al., 
1997). High insulin levels have been shown to inhibit hepatic glucose 
production by means of stimulation of GCK gene transcription (Celika et al., 
2009). In this study, the changes in GCK could be partly attributed to the 
insulin level because plasma insulin level was elevated in Trigonella treated 
rats than the diabetic one and become near to control group. These data are 
in agreement with finding about other medical plants like, Caffeic acid 
phenethyl ester (CAPE) treatment (Celika et al., 2009), Persian Shallot 
treatment (Mahmoodi et al., 2013), and Cinnamon extract treatment 
(Soliman et al., 2013) 
 To our knowledge, we report for the first time that Trigonella 
supplementation causes an increase in GCK mRNA expression in liver of 
diabetic rats. Current results is consistent with previous studies that showed 
GCK mRNA expression increase in Naringin (Jung et al., 2004), 1-
Deoxynojirimycin (Li et al., 2011) and epigallocatechin gallate, a main 
polyphenolic constituent of green tea (Nakagawa et al., 2002) treated rats. In 
liver, an increase in GCK activity leads to enhanced glycolysis and hepatic 
glucose uptake (Grimsby et al., 2003). The increase in insulin concentrations 
in diabetic rats supplemented with Trigonella could either be caused by 
direct stimulation of insulin secretion in response to feeding or by a 
protective effect of Trigonella on the pancreas. The results of our study are in 
line with recently published data, which suggest that other plants preserves 
and protects the pancreas by its strong antioxidative capacity (Jung et al., 
2004; Song et al., 2003). This would ultimately lead to enhanced pancreatic 
function and improved insulin secretion in response to feeding. The lipid 
peroxidation may attribute to the hypoinsulinemia caused by STZ 
progressive deterioration of normal pancreatic β-cell function. This 
hypoinsulinemia induced an increase in the activity of fatty acyl Co-A 
oxidase that initiate the β-oxidation of fatty acids resulting in lipid 
peroxidation (Oberley , 1988; Baynes and Thorpe, 1996). In the previous 
study, administration of Trigonella extract significantly decreased lipid 
peroxide biomarkers; Thiobarbituric acid reactive substances (TBARS) in 
liver of diabetic rats. These results are underlined by the significant increase 
in hepatic activities and expressions of antioxidant enzymes in diabetic rats 
treated with Trigonella (Salah-eldin, 2008). 
 IGF-1 is a single polypeptide with 70 amino acids, widely expressed 
in mammal tissues and it has similar structures and functions like those of 
insulin (Pankov, 1999; Thrailkill, 2000). The liver is the main source of 
circulating IGF-1 (Sjogren et al., 2002), thus hepatic tissues were used for 
the expression study. IGF-1 induced its effect via binding to specific 
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receptors on target cells. Insulin regulates IGF-1 expression either directly or 
indirectly by increasing the number of growth hormone hepatic receptors. 
Because of IGF-1 induced glucose taken and improved the insulin sensitivity 
(Scharf et al., 2000; Reinmuth et al., 2002), increased its expression 
augmented this effect in diabetic rats treated by Trigonella. Therefore, the 
increase of gene expression of IGF-1 by Trigonella administration can be 
considered a new mechanism of antidiabetic effect of this herbal medical 
plant. In the present study, hepatic IGF-1 gene expression was not 
significantly changed in STZ-diabetic rats compared to the control non-
diabetic one. On contrary, previous findings reported by Goya et al. (1999) 
and Li et al. (2004) indicating a down regulation of IGF-1 in diabetic rats 
after acute or chronic administration of diabetic-induce agent; Alloxan. IGFs 
are part of a complex system that cells use to communicate with their 
physiologic environment, since at high concentrations is capable of 
activating the insulin receptor, it can also complement for the effects of 
insulin (Scarth, 2006). As discussed above, the antihyperglycemic effect of 
Trigonella was observed via up-regulation of IGF-1 gene expression in 
diabetic rats.  
 GLUT-2 is a transmembrane carrier protein that enables passive 
glucose movement across cell membranes. It is the principal transporter for 
transfer of glucose between liver and blood and for renal glucose 
reabsorption (Freitas et al., 2005). In this study, the normalization of GLUT-
2 expression after Trigonella administration may be a reflect pathway to 
reverse the glucose uptake in liver cells while Trigonella administration 
increases IGF-1 expression to induce insulin like effects. 
 In summary, there has been a growing interest in hypoglycemic 
agents from natural products of Saponins found in Trigonella hamosa L. In 
current study Trigonella significantly reduced glucose level, while gently 
increases insulin serum level. These findings suggest that, Trigonella could 
restore the damaged pancreas and stimulate the secretion of pancreatic 
insulin. Mean-time, Trigonella has probably ability to accelerate the hepatic 
glucose metabolism may be via regulating the expression of the functional 
genes of GCK, IGF-1 and GLUT-2 as documented by RT-PCR studies. In 
fact, this antihyperglycemic action of Trigonella is likely to be associated 




 We can conclude that Trigonella extract induce beneficial effects in 
diabetic-rat models, by affect the genes related to carbohydrate metabolism 
via upregulation of GCK and IGF-1 expressions in a way to control the 
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metabolic biohazards accompanied diabetes. Moreover, Trigonella is a good 
herbal medication with insulin mimetic activity. 
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